Celgene Corporation

CELG 
(NASDAQ) 
 
$ 89,62 <%= Resources.Global.txtDown %>
Updated 19:56:08
Change % -0.65% Stock price decreasing
Change -0.585 Stock price decreasing
Volume 674,343
High $ 90.28
Low $ 0
Open $ 90.28
ISIN
Prev close $ 90.20
# of shares 705.26M
Market cap 63,202M USD
Intraday

Celgene Corporation
Market is closed, opens at 14:30
 
Price development Latest 1 week 1 month 3 months 6 months 1 year
 
  89.62 -2.3% Stock price decreasing -9.4% Stock price decreasing -4.1% Stock price decreasing 4.2% Stock price increasing 5.3% Stock price increasing
Powered by TradingView

Related

Latest 1 week 1 month 3 months 6 months 1 year
YTD
 
Competitors Open
 
Bristol-Myers Squibb Company 42.83 -3.1% Stock price decreasing -13.2% Stock price decreasing -5.3% Stock price decreasing -13.9% Stock price decreasing -24.5% Stock price decreasing -17.6% Stock price decreasing
 
Johnson & Johnson 128.47 -4.6% Stock price decreasing -9.6% Stock price decreasing -6.8% Stock price decreasing -0.3% Stock price decreasing 2.1% Stock price increasing -0.4% Stock price decreasing
 
Merck & Company Inc (new) 81.43 0.6% Stock price increasing -3.7% Stock price decreasing 10.8% Stock price increasing 7.4% Stock price increasing 30.2% Stock price increasing 6.6% Stock price increasing
 
Pfizer Inc 42.95 0.5% Stock price increasing -1.6% Stock price decreasing 10.2% Stock price increasing 1.6% Stock price increasing 15.1% Stock price increasing -1.6% Stock price decreasing
 
Amgen Inc 176,46 0.2% Stock price increasing -5.7% Stock price decreasing 0.1% Stock price increasing -12.6% Stock price decreasing -7.4% Stock price decreasing -9.4% Stock price decreasing
 
Gilead Sciences Inc 65.33 -4.0% Stock price decreasing -5.8% Stock price decreasing 5.6% Stock price increasing -4.7% Stock price decreasing -15.6% Stock price decreasing 4.4% Stock price increasing
 
Vertex Pharmaceuticals Incorpo.. 174,36 -1.1% Stock price decreasing -5.2% Stock price decreasing 3.5% Stock price increasing -10.1% Stock price decreasing -1.7% Stock price decreasing 5.2% Stock price increasing
 
Astrazeneca PLC ORD SHS $0.25 6,411.93 1.3% Stock price increasing 0.5% Stock price increasing 10.3% Stock price increasing 15.4% Stock price increasing 14.7% Stock price increasing 9.2% Stock price increasing
 
Novartis AG 94.17 5.5% Stock price increasing 1.8% Stock price increasing 24.9% Stock price increasing 6.6% Stock price increasing 14.5% Stock price increasing 9.7% Stock price increasing
 
Takeda PHARM.CO.LTD. 30.47 -5.6% Stock price decreasing -0.2% Stock price decreasing -4.8% Stock price decreasing -13.5% Stock price decreasing -16.2% Stock price decreasing 5.3% Stock price increasing
 
Biogen Inc 233,65 0.0% Stock price increasing -2.3% Stock price decreasing 2.1% Stock price increasing -31.1% Stock price decreasing -34.9% Stock price decreasing -22.4% Stock price decreasing
 
Roche Hldg Sp.Adr 1/8 29.76 -0.8% Stock price decreasing -4.0% Stock price decreasing 4.3% Stock price increasing 5.5% Stock price increasing 21.5% Stock price increasing 15.2% Stock price increasing

Company profile

Celgene is a biopharmaceutical firm that discovers, develops, and markets therapeutics for the treatment of cancer and immunological diseases. Celgene markets Thalomid and Pomalyst to treat multiple myeloma and Revlimid, a less toxic thalidomide derivative, to treat myelodysplastic syndromes, multiple myeloma, and mantle cell lymphoma. Acquisitions have brought MDS drug Vidaza, T-cell lymphoma drug Istodax, and cancer drug Abraxane. The firm's first immunology drug, Otezla, was approved in the U.S. in 2014. Recent acquisitions of Juno and Impact bring additional drugs for Celgene's blood cancer pipeline.

Peers

Instruments Last Change  
Bristol-Myer.. 42.83 -1.2% Stock price decreasing
Johnson & Jo.. 128.47 -1.4% Stock price decreasing
Merck & Comp.. 81.43 0.0% Stock price increasing
Pfizer Inc 42.95 0.4% Stock price increasing
Amgen Inc 176,46 -1.1% Stock price decreasing
Gilead Scien.. 65.33 0.4% Stock price increasing
Vertex Pharm.. 174,36 0.1% Stock price increasing
Astrazeneca .. 6,411.93 0.3% Stock price increasing
Novartis AG 94.17 0.7% Stock price increasing
Takeda PHARM.. 30.47 -0.7% Stock price decreasing
100,100,100,100,100,0,0,28,28,28
Biogen Inc 233,65 1.0% Stock price increasing
0,56,38,27,100,42,61,31,41,66
Roche Hldg S.. 29.76 0.7% Stock price increasing
0,0,0,91,91,91,100,100,100,100

Copyright Berlingske Media 2019  Cookie- and Privacy policy  |  Cookies  |   General terms of trade  |   Terms of use and IP rights
Quote information is delivered by Morningstar.
Data is delayed 15-20 minutes according to the distribution agreements set by the different exchanges.
 
22 July 2019 20:11:32
(UTC+00:00) Dublin, Edinburgh, Lisbon, London
Version: LiveBranchBuild_20190703.1 - EUROWEB1 - 2019-07-22 21:11:32 - 2019-07-22 20:11:32 - 1000 - Website: OKAY